Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUPILUMAB vs DYDROGESTERONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DUPILUMAB vs DYDROGESTERONE: Safety Overview

Metric DUPILUMAB DYDROGESTERONE
Total FAERS Reports 379,249 340
Deaths Reported 1,536 13
Death Rate 0.4% 3.8%
Hospitalizations 17,008 112
Average Patient Age 44.7 yrs 33.8 yrs
% Female Patients 61.2% 94.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer sanofi-aventis U.S. LLC N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription Discontinued